Skip to content
Saturday, March 15, 2025
GLP-1 Watch
All the latest news and updates about GLP-1 Drugs
Search
Search
Privacy Policy
The Evolving Landscape of GLP-1 Drugs: Innovations, Market Trends, and Health Implications
Home
2025
March
7
FDA ODD given to Plus Therapeutics’ injectable radiotherapy
GLP-1 News
FDA ODD given to Plus Therapeutics’ injectable radiotherapy
March 7, 2025
admin
The FDA has granted orphan drug designation to Plus Therapeutics’ injectable radiotherapy, Rhenium (186Re) Obisbemeda.
Post navigation
Why don’t celebrities admit to taking Ozempic? Expert answers at India Today Conclave – India Today
The trillion-dollar opportunity in women’s health